Parallel Advisors’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Parallel Advisors’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-95	Closed	–	–	2319
2017 Q1	$0	Hold	95	–	–	﹤0.01%	2174
2016 Q4	$0	Buy	+95	New	+$486	﹤0.01%	1817

Other funds holding OSIR

FIM

Freedom Investment Management Hartford, Connecticut $359M AUM 23.01% 1-Year Est. Return

Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return

MAM

Meeder Asset Management Dublin, Ohio $1.96B AUM 48.96% 1-Year Est. Return

Parallel Advisors's OSIR Position: Q2 2017 in Review

Parallel Advisors sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2017, closing a stake of 95 shares.

Parallel Advisors first reported a position in OSIR in Q4 2016 and held it in 2 quarters. The position peaked at $0 in Q1 2017. 3 funds tracked by Wall St. Rank hold OSIR as of Q2 2017.

Parallel Advisors reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Parallel Advisors sold 95 Osiris Therapeutics, Inc. Common Stock shares in Q2 2017.
Parallel Advisors first reported a position in Osiris Therapeutics, Inc. Common Stock in Q4 2016 and held it in 2 quarters.
Parallel Advisors's Osiris Therapeutics, Inc. Common Stock position peaked at $0 in Q1 2017.
3 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2017.

Based on Parallel Advisors's 13F filing for Q2 2017, filed 7 Aug 2017.